Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

Nature Genetics volume 45, pages 133–135 (2013)Cite this article

Subjects

Abstract

Uveal melanoma is the most common primary cancer of the eye and often results in fatal metastasis. Here, we describe mutations occurring exclusively at codon 625 of the SF3B1 gene, encoding splicing factor 3B subunit 1, in low-grade uveal melanomas with good prognosis. Thus, uveal melanoma is among a small group of cancers associated with SF3B1 mutations, and these mutations denote a distinct molecular subset of uveal melanomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Association of mutation status with clinical outcome in uveal melanoma.

Similar content being viewed by others

Accession codes

Primary accessions

Gene Expression Omnibus

Sequence Read Archive

References

  1. Harbour, J.W. Pigment Cell. Melanoma Res. 25, 171–181 (2012).

    Article  CAS  Google Scholar 

  2. Harbour, J.W. et al. Science 330, 1410–1413 (2010).

    Article  CAS  Google Scholar 

  3. Onken, M.D. et al. Invest. Ophthalmol. Vis. Sci. 49, 5230–5234 (2008).

    Article  Google Scholar 

  4. Van Raamsdonk, C.D. et al. Nature 457, 599–602 (2009).

    Article  CAS  Google Scholar 

  5. Papaemmanuil, E. et al. N. Engl. J. Med. 365, 1384–1395 (2011).

    Article  CAS  Google Scholar 

  6. Wang, L. et al. N. Engl. J. Med. 365, 2497–2506 (2011).

    Article  CAS  Google Scholar 

  7. Ellis, M.J. et al. Nature 486, 353–360 (2012).

    Article  CAS  Google Scholar 

  8. Van Raamsdonk, C.D. et al. N. Engl. J. Med. 363, 2191–2199 (2010).

    Article  CAS  Google Scholar 

  9. Golas, M.M., Sander, B., Will, C.L., Luhrmann, R. & Stark, H. Science 300, 980–984 (2003).

    Article  CAS  Google Scholar 

  10. Visconte, V. et al. Blood 120, 3173–3186 (2012).

    Article  CAS  Google Scholar 

  11. An, M. & Henion, P.D. Int. J. Dev. Biol. 56, 223–237 (2012).

    Article  CAS  Google Scholar 

  12. Visconte, V., Makishima, H., Maciejewski, J.P. & Tiu, R.V. Leukemia 26, 2447–2454 (2012).

    Article  CAS  Google Scholar 

  13. Isono, K., Mizutani-Koseki, Y., Komori, T., Schmidt-Zachmann, M.S. & Koseki, H. Genes Dev. 19, 536–541 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by US National Institutes of Health (NIH) grants R01 CA16187001 (A.M.B. and J.W.H.) and CA12597007 (J.W.H.), the Melanoma Research Alliance (J.W.H.), the Melanoma Research Foundation (J.W.H.), the Tumori Foundation (J.W.H.), Research to Prevent Blindness, Inc. (J.W.H.) and awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness, Inc., Unrestricted grant and the US NIH Vision Core grant P30 EY02687c. E.D.O.R. was supported under US NIH training grant 5 T32 AR007279-32. We thank L. Cao for technical assistance and C. Jordan for exome capture. We thank the patients who volunteered to participate in the study in order to make this work possible. This study was approved by the Human Studies Committee at Washington University in St. Louis, and informed consent was obtained from all subjects.

Author information

Author notes

  1. J William Harbour

    Present address: Present addresses: Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA, and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.,

  2. J William Harbour and Anne M Bowcock: These authors jointly directed this work.

Authors and Affiliations

  1. Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA

    J William Harbour, Michael D Onken & Lori A Worley

  2. Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA

    Elisha D O Roberson, Hima Anbunathan & Anne M Bowcock

Authors
  1. J William Harbour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisha D O Roberson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hima Anbunathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael D Onken
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lori A Worley
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anne M Bowcock
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.W.H. participated in the conception and design of the study, provided the samples used in the study, performed biostatistical analysis and drafted the manuscript. E.D.O.R. performed the analysis of next-generation sequencing data and bioinformatics analysis. H.A. performed Sanger sequencing. M.D.O. performed bioinformatics analysis. L.A.W. managed the tissue bank and clinical database and prepared DNA and RNA samples. A.M.B. participated in the conception and design of the study and analyzed the data. All authors contributed to the final draft of the manuscript.

Corresponding authors

Correspondence to J William Harbour or Anne M Bowcock.

Ethics declarations

Competing interests

J.W.H., A.M.B. and Washington University may receive income from the licensing of related technology by Washington University to Castle Biosciences, Inc. This work was not supported by Castle Biosciences, Inc.

Supplementary information

Supplementary Text and Figures

Supplementary Methods, Supplementary Tables 1 and 2 and Supplementary Figures 1–3 (PDF 752 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harbour, J., Roberson, E., Anbunathan, H. et al. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 45, 133–135 (2013). https://doi.org/10.1038/ng.2523

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.2523

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer